Phase II Study of Rabbit Anti-Thymocyte Globulin, Cyclosporine, and Granulocyte Colony Stimulating Factor in Patients with Aplastic Anemia and Myelodysplastic Syndrome

BACKGROUND: Severe aplastic anemia (AA) is treated with equine anti-thymocyte globulin (hATG) and cyclosporine with response rates up to 65%. Rabbit anti-thymocyte globulin (rATG, Thymoglobulin(®)) has been used successfully in relapsed and refractory patients. Immunosuppressive therapy is also effe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garg, Ravin, Faderl, Stefan, Garcia-Manero, Guillermo, Cortes, Jorge, Koller, Charles, Huang, Xuelin, York, Sergerne, Pierce, Sherry, Brandt, Mark, Beran, Miloslav, Borthakur, Gautam, Kantarjian, Hagop, Ravandi, Farhad
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217203/
https://ncbi.nlm.nih.gov/pubmed/19242494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2009.28
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars